A detailed history of Quent Capital, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Quent Capital, LLC holds 147 shares of TECH stock, worth $10,501. This represents 0.0% of its overall portfolio holdings.

Number of Shares
147
Previous 147 -0.0%
Holding current value
$10,501
Previous $10,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jun 14, 2024

BUY
$52.83 - $78.22 $581 - $860
11 Added 8.09%
147 $11,000
Q4 2023

Jan 19, 2024

BUY
$52.83 - $78.22 $581 - $860
11 Added 8.09%
147 $11,000
Q1 2023

Jun 14, 2024

SELL
$71.62 - $86.62 $787 - $952
-11 Reduced 7.48%
136 $10,000
Q4 2022

Jan 19, 2023

BUY
$80.67 - $352.29 $9,438 - $41,217
117 Added 615.79%
136 $0
Q2 2022

Aug 08, 2022

SELL
$322.67 - $449.65 $7,744 - $10,791
-24 Reduced 55.81%
19 $7,000
Q1 2022

May 12, 2022

BUY
$353.85 - $487.79 $15,215 - $20,974
43 New
43 $19,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.